Slimjaro Tirzepatide (GLP-1/GIP) Program for Chronic Weight Management

Experience medical weight management designed for safety, results, and continuity of care. Our physician-guided tirzepatide weight loss program integrates FDA-approved incretin therapy (Zepbound), stepwise dose titration, ongoing monitoring, and lifestyle coaching delivered via secure telehealth or in-clinic visits.

How it works

Tirzepatide is a dual GIP and GLP-1 receptor agonist that helps regulate appetite, satiety, and insulin response. You self-administer a once-weekly injection; our clinicians adjust doses gradually to improve tolerability and outcomes. We track weight, vitals, labs, and side effects to optimize tirzepatide weight loss while prioritizing safety and adherence.

Eligibility

Adults 18–75 with BMI ≥30, or ≥27 with a weight-related condition (e.g., hypertension, dyslipidemia, obstructive sleep apnea, or type 2 diabetes) may qualify. We screen for exclusions, including pregnancy, a personal/family history of medullary thyroid carcinoma (MTC) or MEN2, prior pancreatitis, gallbladder disease, severe GI disorders, and medication interactions.

Clinical results

In pivotal trials, tirzepatide plus reduced-calorie diet and increased activity produced clinically meaningful weight reduction and improved cardiometabolic markers versus placebo. Many participants achieved ≥15% body-weight loss with continued therapy and support. Individual results vary, and sustained habits are essential for durable benefits. Tirzepatide weight loss outcomes depend on adherence and tolerability.

Getting started

1) Complete a secure medical assessment and baseline labs. 2) Meet your clinician via telehealth to confirm eligibility; if appropriate, a prescription is issued. 3) Begin at a starter dose with onboarding education and supplies. 4) Attend scheduled check-ins for titration, side-effect management, and lifestyle guidance.

Coverage and cost

We verify insurance eligibility for Zepbound, estimate copays, and apply manufacturer savings when available. Transparent cash pricing is provided up front, with pharmacy coordination and home delivery options.

Ongoing support

Our team provides structured touchpoints, nutrition and activity frameworks, behavior strategies, and complication monitoring. Data-informed adjustments help maintain momentum and durable tirzepatide weight loss.

Important Safety Information

Boxed Warning: Tirzepatide may increase the risk of thyroid C-cell tumors. Do not use if you or a family member has had MTC or MEN2. Seek care for neck mass, hoarseness, trouble swallowing, or shortness of breath.

• Do not use during pregnancy; not for type 1 diabetes.
• Common effects: nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite.
• Serious risks: pancreatitis, gallbladder problems, kidney injury, severe allergic reactions.
• May cause low blood sugar with insulin or sulfonylureas; monitoring and dose adjustments may be needed.
• Slows gastric emptying; may affect absorption of certain oral medicines.

FAQs

How long is treatment? We reassess regularly; many continue beyond 12 months to support maintenance.

Will weight return if I stop? Some regain can occur. We plan maintenance strategies and consider tapering when appropriate.

Can I travel? Yes. The once-weekly pen is portable; we advise on timing and storage.

Start today: Complete a Slimjaro assessment to learn if tirzepatide weight loss is appropriate for you.